The FDA announced that Teleflex, and their subsidiary Arrow International, are recalling the ARROW Endurance Extended Dwell Peripheral Catheter System after reports of catheter separation or leakage. Teleflex/Arrow International reports 83 complaints related to this issue. There have been 18 reported injuries and no deaths, the FDA stated, noting that the agency has identified this as a Class I recall, the most serious type of recall. “Use of these devices may cause serious injuries or death,” stated the FDA in its recall notice, which indicates the date the recall was initiated by the firm as May 19, 2023.
Protect Your Portfolio Against Market Uncertainty
- Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter.
- Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on TFX:
- Teleflex Incorporated Announces Global Recall of Rüsch Endotracheal Tubes
- Teleflex Announces Partnership with Insighters Medical for Exclusive Distribution of the Insighters® Video Laryngoscope System
- Teleflex partners with Insighters Medicals for laryngoscope system distribution
- Teleflex downgraded to Hold at Needham as urologists reduce use of UroLift
- Teleflex downgraded to Hold from Buy at Needham